Communiqués Gamida Cell Ltd.

Actions

GMDA

IL0011552663

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets Autres places de cotation 18:54:51 24/05/2024			Varia. 5j.	Varia. 1 janv.
0,0170 ^USD	+2,41%		-.--%	-

27/05/25	Gamida Cell Ltd. a annulé l'acquisition de bluebird bio, Inc. (NasdaqGS : BLUE) auprès de BlackRock, Inc. (NYSE : BLK), The Vanguard Group, Inc. et d'autres parties.	CI
22/07/24	HOOKIPA Pharma nomme Malte Peters au poste de PDG et Terry Coelho au poste de directeur financier	MT

Communiqués

27/03/24	Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management	AQ
27/03/24	Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update	AQ
22/03/24	Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results	AQ
23/02/24	Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®	AQ
29/01/24	Gamida Cell Actively Pursuing Strategic Alternatives	AQ
17/01/24	Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®	AQ
28/11/23	Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023	AQ
20/11/23	Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference	AQ
14/11/23	Gamida Cell: Q3 Earnings Snapshot	AQ
14/11/23	Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update	AQ
04/11/23	Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting	AQ
01/11/23	Gamida Cell to Report Third Quarter 2023 Financial Results	AQ
16/10/23	Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201	BU
09/10/23	Gamida Cell Issues Update on Israel Operations	BU
07/10/23	Gamida Cell : Statement Regarding Attacks on Israel	PU
03/10/23	Gamida Cell to Present Corporate Highlights at 2023 Cell and Gene Meeting on the Mesa	AQ
02/10/23	Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa	BU
29/09/23	Gamida Cell to Present at Society for Immunotherapy of Cancer's 38th Annual Meeting	AQ
28/09/23	Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting	BU
27/09/23	First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv)	BU
31/08/23	Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference	BU
14/08/23	Gamida Cell: Q2 Earnings Snapshot	AQ
14/08/23	Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update	BU
01/08/23	Gamida Cell to Report Second Quarter 2023 Financial Results	BU
12/07/23	Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection after Transplantation with Gamida Cell's Omisirge	AQ